Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : VLP-N-00026
| Cat. No. | VLP-N-00026 |
| Description | Virus-Like Particles that contain structurally intact fusion protein of Human GPRC5D and GFP, designed for antibody screening and ligand binding assays etc. |
| Gene Abbr | GPRC5D-GFP |
| Applications | Human GPRC5D-GFP virus-like particles (VLPs) have a variety of applications in scientific research, particularly in the fields of molecular biology, immunology, and virology. Here are some specific uses: Receptor Function Studies: Researchers can use GPRC5D-GFP VLPs to study the function of the GPRC5D receptor, a member of the G protein-coupled receptor (GPCR) family. Because the particles contain the receptor tagged with GFP (green fluorescent protein), they can be visually tracked and analyzed using fluorescence microscopy. Protein-Protein Interactions: VLPs can be used to study interactions between GPRC5D and other proteins, including intracellular signaling molecules. The GFP tag facilitates identification of interaction partners through various biochemical techniques, such as co-immunoprecipitation and pull-down assays. Drug Discovery and Screening: Researchers can use these particles to screen for potential drug candidates that interact with GPRC5D. The fluorescence provided by the GFP tag can be used as a readout for high-throughput screening assays. Vaccine Development: Given their virus-like properties, these particles can be used in vaccine development, particularly as a platform for presenting antigens in a highly immunogenic form. Signaling Pathways: VLPs facilitate the study of downstream signaling pathways activated by the GPRC5D receptor. Researchers can assess the biochemical cascades involved and their physiological consequences. |
| Storage | -80˚C |
| Shipping | Dry ice |
Human G protein-coupled receptor class C, group 5, member D (GPRC5D) is a member of the large G protein-coupled receptor (GPCR) superfamily, known for its key roles in various physiological processes and potential as a therapeutic target. GPCRs typically span the cell membrane and are involved in transmitting signals from the outside of the cell to the inside of the cell, affecting a variety of physiological processes. GPRC5D expression has been detected in various tissues, including kidney, lung, and bone marrow, suggesting that it may have a wide range of physiological roles. Some studies have shown that GPRC5D is associated with multiple myeloma, a blood cancer, making it an interesting target for therapeutic intervention.
Virus-like particles (VLPs) are non-infectious virus mimics composed of viral structural proteins and do not contain viral genetic material. Human GPRC5D-GFP VLPs combine the structural integrity and functional capabilities of VLPs with the visualization and tracking convenience provided by GFP. GPRC5D was first cloned in-frame with GFP to ensure that the fusion protein maintained the biological function and fluorescent properties of GFP. This chimeric construct is then inserted into a suitable expression vector, allowing for efficient production of the fusion protein in host cells. After expression, the chimeric protein self-assembles into VLPs, encapsulating the fusion protein in non-infectious but structurally accurate virus-like particles. These particles can present proteins in their native conformation, making them an excellent model for studying viral assembly, entry mechanisms, and host interactions, as well as a powerful platform for vaccine development and drug delivery systems.
A: Human GPRC5D-GFP Virus-Like Particles can be used in cancer research to study the behavior and characteristics of multiple myeloma cells. By attaching a fluorescent marker, such as GFP, to the particles, researchers can visualize the binding and internalization of the particles into cancer cells in real-time. Moreover, these particles can be loaded with therapeutic agents or imaging agents, enabling targeted drug delivery or non-invasive imaging of multiple myeloma cells. This may aid in the development of more effective treatments and diagnostics for this type of cancer.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
I recently used the Human GPRC5D-GFP Virus-Like Particles for gene delivery experiments in my lab, and I must say that I am highly impressed with the efficiency of this system. The particles were able to efficiently deliver the GFP gene into a wide range of cell types, resulting in strong and consistent expression. The GFP fluorescence was visible within hours after transfection, indicating the rapid uptake of the particles by the cells.
As a researcher focused on GPRC5D, I have been using the Human GPRC5D-GFP Virus-Like Particles to study the expression and function of this important receptor. The particles have proven to be an extremely valuable tool in our experiments. The GFP fusion allows us to easily visualize GPRC5D expression in live cells, providing valuable insights into its localization and dynamics.
The Human GPRC5D-GFP Virus-Like Particles have become an essential tool in our lab for viral transduction experiments. Working with these particles has been incredibly convenient and safe, as they provide a ready-to-use system without the need for handling and manipulating live viruses.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.